Ultragenyx Pharmaceutical Inc. (RARE)
NASDAQ: RARE · Real-Time Price · USD
36.23
+0.03 (0.08%)
At close: Dec 12, 2025, 4:00 PM EST
36.26
+0.03 (0.08%)
After-hours: Dec 12, 2025, 7:23 PM EST
Ultragenyx Pharmaceutical Market Cap
Ultragenyx Pharmaceutical has a market cap or net worth of $3.49 billion as of December 12, 2025. Its market cap has decreased by -20.22% in one year.
Market Cap
3.49B
Enterprise Value
3.90B
1-Year Change
-20.22%
Ranking
Category
Stock Price
$36.23
Market Cap Chart
Since January 31, 2014, Ultragenyx Pharmaceutical's market cap has increased from $1.19B to $3.49B, an increase of 193.47%. That is a compound annual growth rate of 9.49%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 12, 2025 | 3.50B | -10.03% |
| Dec 31, 2024 | 3.88B | -1.06% |
| Dec 29, 2023 | 3.93B | 20.90% |
| Dec 30, 2022 | 3.25B | -43.33% |
| Dec 31, 2021 | 5.73B | -32.17% |
| Dec 31, 2020 | 8.45B | 242.48% |
| Dec 31, 2019 | 2.47B | 12.20% |
| Dec 31, 2018 | 2.20B | 11.33% |
| Dec 29, 2017 | 1.98B | -31.24% |
| Dec 30, 2016 | 2.87B | -34.05% |
| Dec 31, 2015 | 4.36B | 211.25% |
| Dec 31, 2014 | 1.40B | 17.73% |
| Jan 31, 2014 | 1.19B | - |
View and export this data all the way back to 2014. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 903.78B |
| Johnson & Johnson | 505.98B |
| AbbVie | 395.86B |
| UnitedHealth Group | 305.02B |
| AstraZeneca | 282.91B |
| Novartis AG | 256.01B |
| Merck & Co. | 245.75B |
| Novo Nordisk | 223.42B |